Clinical Trial: Safety and Efficacy of NDTx-03 in Children and Adolescents With ASD or SCD

U.S., Aug. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07770867) titled 'Safety and Efficacy of NDTx-03 in Children and Adolescents With ASD or SCD' on Aug. 13.

Brief Summary: The purpose of this study is to evaluate the safety of NDTx-03 used together with treatment as usual (TAU) and to determine whether NDTx-03 plus TAU is more effective than TAU alone in improving social situation recognition and interaction in children and adolescents with autism spectrum disorder (ASD) or social communication disorder (SCD).

Study Start Date: Aug., 2026

Study Type: INTERVENTIONAL

Condition: Autism Spectrum Disorder Social Communication Disorder

Intervention: DEVICE: NDTx-03

NDTx-03 is digital medical device ...